Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-829-7 | CAS number: 922165-31-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- November 15, 2007 - January 15, 2008
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: This study has been performed similar to OECD 473 Guideline and according to GLP principles. Deviations: - No information in the report to determine if an independent repeat was performed.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: Guideline for Genotoxicity Studies (Notificationn 1604 of Iyakushin, November 1, 1999, Ministry of Health, Labour and Welfare)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- No information in the report to determine if an independent repeat was performed.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 1,4-bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate
- EC Number:
- 618-829-7
- Cas Number:
- 922165-31-9
- Molecular formula:
- C20H36O8
- IUPAC Name:
- 1,4-bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate
- Details on test material:
- - Name of test material (as cited in study report): CH-CA
- Description: Transparent liquid
- Stability under test conditions: Unknown
- Storage condition of test material: Stored at room temperature in a sealed container
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: Chinese Hamster Lung (CHL/IU)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Eagle's MEM supplemented with 10% heat-inactivated fetal bovine serum was mixed with the penicillin-streptomycin mixture containing 10000 units/mL penicillin and 10000 µg/mL streptomycin at the ratio of 100:1.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes, with a modal chromosome number of 25 and approximately 15 hours of cell cycle.
- The cells were subcultured until 16 passages and used for the growth inhibition test and cytogenetic test.
- Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital and 5,6-benzoflavone induced rat liver S9 mix
- Test concentrations with justification for top dose:
- Growth inhibition test, with and without S9-mix: 0, 5, 10, 50, 100, 250, 500, 1000, 2500 and 5000 µg/mL (6h and 24h exposure, 24h fixation)
Cytogenetic test, without S9-mix: 350, 700 and 1400 µg/mL (6h exposure, 24h fixation)
Cytogenetic test, with S9-mix: 875, 1750 and 3500 µg/mL (6h exposure, 24h fixation)
Cytogenetic test, without S9-mix: 450, 900 and 1800 µg/mL (24h exposure, 24h fixation)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethyl sulfoxide (DMSO)
- Justification for choice of solvent/vehicle: Based on the information provided by the Sponsor, the solubility and dispersion characteristics of the test substance were assessed for the highest dose in water for injection, saline and DMSO. The test substance was insoluble in water for injection and saline, but was soluble in DMSO. Therefore, DMSO was determined as the vehicle for this study.
Controlsopen allclose all
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without S9-mix
Migrated to IUCLID6: dose 0.05 µg/mL (6h and 24h exposure)
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- with S9-mix
Migrated to IUCLID6: dose 20 µg/mL (6h exposure)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 24h
- Exposure duration: 6h (with and without S9 mix), 24h (without S9 mix)
- Fixation time (start of exposure up to fixation or harvest of cells): 24h
SPINDLE INHIBITOR (cytogenetic assays): colcemid
STAIN (for cytogenetic assays): Giemsa solution diluted with phosphate buffer
NUMBER OF REPLICATIONS: duplicate
NUMBER OF CELLS EVALUATED: 200 metaphases/dose
DETERMINATION OF CYTOTOXICITY
- Method used in the growth inhibition test: Spectrophotometrical absorbance of solutions was measured using the ELISA reader (VERSA matTM, Molecular Devices, USA). Since cytotoxicity was observed, 50% inhibition concentration (IC50) was calculated to determine the highest dose for the cytogenetic test.
- Method used in the cytogenetic test: The number of cells of all well dishes were counted using hemocytometer and cell proliferation rate was calculated.
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: no - Evaluation criteria:
- Mean frequencies of chromosome aberration cells: <5%: negative; >5%-<10%: equivocal; >10%: positive.
- Statistics:
- For the aberration cells data, Fisher's exact test was used for the negative control versus treated groups comparison, and the negative control versus positive control. Group comparisonwere performed at the 5.0% one-tailed probability level. The entire statistical analysis was performed using the statistical program (PC SAS BUNDLE, SAS (version 9.1.3, SAS Institute Inc., Cary, NC, USA)).
Results and discussion
Test results
- Species / strain:
- mammalian cell line, other: Chinese Hamster Lung (CHL/IU)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- proliferation rate decreased at the highest tested dose in the short and continuous treatment time.
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: The deposition of the test substance was not observed in the short time treatment with and without S9-mix and in the continuous treatment of all doses of the test substance.
RANGE-FINDING/SCREENING STUDIES: As a result of the growth inhibition test, cytotoxicity was observed in the short time treatment with and without S9-mix and in the continuous treatment. Based on the growth inhibition test, 50% inhibition concentration (IC50) was calculated as 3563 and 1325 µg/mL for the short time treatment with and without S9-mix, respectively, and as 1721 µg/mL for the continuous treatment.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
In a chromosome aberration test performed similar to OECD 473 and GLP, the test substance, CH-CA, did not show chromosome aberrations with and without S9-mix using chinese hamster lung cell (CHL/IU). The number of aberration cells in the positive controls were significantly increased when compared with the negative control.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.